Endocan Levels in Peripheral Blood Predict Outcomes of Acute Respiratory Distress Syndrome

Table 5

Organ dysfunctions in patients with acute respiratory distress syndrome with low or high plasma endocan levels.

	Endocan ≥ 4.96 ng/mL; (𝑛=15)	Endocan < 4.96 ng/mL; (𝑛=27)	𝑃 value
Organ dysfunction; (duration of hospital stay)
Septic shock, 𝑛 (%)	9 (60)	5 (18.5)	0.015*
Renal failure, 𝑛 (%)	8 (53)	5 (18.5)	0.035*
Coagulopathy, 𝑛 (%)	5 (33)	4 (14.8)	0.242
Hepatic dysfunction, 𝑛 (%)	4 (27)	8 (30)	1.0
Organ dysfunction; (Within 7 days)
Septic shock, 𝑛 (%)	7 (47)	3 (11)	0.020*
Renal failure, 𝑛 (%)	4 (27)	2 (7.4)	0.164
Coagulopathy, 𝑛 (%)	5 (33)	1 (3.7)	0.016*
Hepatic dysfunction, 𝑛 (%)	3 (20)	3 (11)	0.649

The occurrence of organ dysfunctions was compared in patient groups with low (<4.96 ng/mL) and high (≥4.96 ng/mL) plasma levels of endocan during hospital stay or within 7 days. Asterisk indicates statistically significant difference between patient groups with low and high plasma endocan levels (^∗𝑃≦0.05;).